Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population‐based study

Insulin resistance: Genetic associations with depression and cognition in population based cohorts

(2019) Sophia Frangou et al.   EXPERIMENTAL NEUROLOGY

Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

(2019) Geert Jan Biessels et al.   DIABETES CARE

Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case–control study

(2019) Ida Kim Wium-Andersen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Insulin signaling pathway protects neuronal cell lines by Sirt3 mediated IRS2 activation

(2018) Neha Mishra et al.   BIOFACTORS

Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications

(2018) Geert Jan Biessels et al.   Nature Reviews Endocrinology

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

(2018) Steven E. Arnold et al.   Nature Reviews Neurology

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease

(2017) Stefan L.C. Geijselaers et al.   JOURNAL OF ALZHEIMERS DISEASE

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype

(2017) Shorena Janelidze et al.   NEUROBIOLOGY OF AGING

Enhanced AMPA Receptor Trafficking Mediates the Anorexigenic Effect of Endogenous Glucagon-like Peptide-1 in the Paraventricular Hypothalamus

(2017) Ji Liu et al.   NEURON

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

(2016) Michael Gejl et al.   Frontiers in Aging Neuroscience

Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: The Malmö Diet and Cancer Study

(2015) M. Rosvall et al.   ATHEROSCLEROSIS

Role of RAGE in Alzheimer’s Disease

(2015) Zhiyou Cai et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Associations of Advanced Glycation End-Products With Cognitive Functions in Individuals With and Without Type 2 Diabetes: The Maastricht Study

(2015) P. J. J. Spauwen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Impaired insulin action in the human brain: causes and metabolic consequences

(2015) Martin Heni et al.   Nature Reviews Endocrinology

The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease

(2014) Christian Hölscher   Alzheimers & Dementia

Normalized Mini-Mental State Examination for Assessing Cognitive Change in Population-Based Brain Aging Studies

(2014) Viviane Philipps et al.   NEUROEPIDEMIOLOGY

Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model

(2013) Emilie Faivre et al.   Alzheimers Research & Therapy

Advanced glycation end product level, diabetes, and accelerated cognitive aging

(2011) K. Yaffe et al.   NEUROLOGY

Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes

(2010) W. Xu et al.   DIABETES